Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoids”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00017199
What this trial is testing

PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell Tumor
Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00093782
What this trial is testing

Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma

Who this might be right for
Metastatic Gastrointestinal Carcinoid TumorPulmonary Carcinoid TumorRecurrent Gastrointestinal Carcinoid Tumor+1 more
National Cancer Institute (NCI) 36
Not applicableWithdrawnNCT04085081
What this trial is testing

Physical Activity Intervention Before and After Surgery in Older Adults With Lung Cancer and Their Family Caregivers

Who this might be right for
CaregiverLobectomy PatientLung Carcinoid Tumor+1 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT02549937
What this trial is testing

A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors

Who this might be right for
Tumors
Hutchmed 130
Not applicableStudy completedNCT02826928
What this trial is testing

Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine Tumors

Who this might be right for
Small-intestine Neuroendocrine Tumors (Carcinoid Tumors)
CHU de Reims 116
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Not applicableStudy completedNCT01398306
What this trial is testing

Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.

Who this might be right for
CarcinomaCarcinoma, Renal CellNeuroendocrine Tumors+2 more
University Medical Center Groningen 40
Testing effectiveness (Phase 2)Study completedNCT00388063
What this trial is testing

Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma

Who this might be right for
Neuroendocrine Carcinoma
Callisto Pharmaceuticals 55
Testing effectiveness (Phase 2)Ended earlyNCT02859064
What this trial is testing

Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres

Who this might be right for
Neuroendocrine TumorsGastrointestinal NeoplasmsCarcinoid Tumors
SCRI Development Innovations, LLC 6
Early research (Phase 1)Study completedNCT00804336
What this trial is testing

Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorCarcinoid TumorPancreatic Neuroendocrine Tumor
Dana-Farber Cancer Institute 22
Testing effectiveness (Phase 2)Ended earlyNCT03420521
What this trial is testing

Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsCarcinoid Tumor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Not applicableUnknownNCT04017104
What this trial is testing

Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging

Who this might be right for
Neuroendocrine TumorsProstate CancerProstatic Neoplasms+3 more
British Columbia Cancer Agency 60
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00965250
What this trial is testing

Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy

Who this might be right for
ThymomaThymic CarcinomaThymic Carcinoid+1 more
National Cancer Institute (NCI) 49
Testing effectiveness (Phase 2)Study completedNCT05361668
What this trial is testing

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

Who this might be right for
Carcinoid SyndromeCarcinoidCarcinoid Tumor+6 more
Crinetics Pharmaceuticals Inc. 36
Testing effectiveness (Phase 2)WithdrawnNCT01172717
What this trial is testing

Study of Panitumumab in the Treatment of Carcinoid Syndrome

Who this might be right for
Carcinoid Syndrome
Boston Medical Center
Early research (Phase 1)Study completedNCT00066404
What this trial is testing

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

Who this might be right for
Cancer
Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)Study completedNCT04197310
What this trial is testing

Cabozantinib and Nivolumab for Carcinoid Tumors

Who this might be right for
Carcinoid TumorCarcinoid Tumor of GI SystemNeuroendocrine Tumors
Dana-Farber Cancer Institute 19
Early research (Phase 1)Study completedNCT01548482
What this trial is testing

Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Adult Solid NeoplasmLung Carcinoid TumorRecurrent Digestive System Neuroendocrine Tumor G1+8 more
National Cancer Institute (NCI) 21
Next Page